Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-15

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for olopatadine hydrochloride from Rising Pharma Holdings, Inc. The approval entails changes to the existing product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)